Cargando…
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
Cervical cancer is the fourth most frequently occurring cancer in women around the world and can affect them during their reproductive years. Since the development of the Papanicolaou (Pap) test, screening has been essential in identifying cervical cancer at a treatable stage. With the identificatio...
Autores principales: | Chrysostomou, Andreas C., Stylianou, Dora C., Constantinidou, Anastasia, Kostrikis, Leondios G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315375/ https://www.ncbi.nlm.nih.gov/pubmed/30572620 http://dx.doi.org/10.3390/v10120729 |
Ejemplares similares
-
Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening
por: Chrysostomou, Andreas C., et al.
Publicado: (2020) -
Architectural Insight into Inovirus-Associated Vectors (IAVs) and Development of IAV-Based Vaccines Inducing Humoral and Cellular Responses: Implications in HIV-1 Vaccines
por: Hassapis, Kyriakos A., et al.
Publicado: (2014) -
HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008) -
HPV vaccination bridges to HPV screening
por: Harper, Diane M, et al.
Publicado: (2020) -
Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)